

Revenues are on the rise at Dechra Pharmaceuticals although the veterinary healthcare company is still experiencing supply issues in the US. Group re...


WPP: JP Morgan upgrades to outperform from neutral. AMEC: BarCap raises target from 1,340p to 1,350p, underweight rating kept. ASOS: Peel Hunt keeps...


Michael Sharp, the man who took over retail chain Debenhams last year, has underlined his faith in the company with the purchase of shares 100,000 sha...


Kevin Chidwick, Chief Financial Officer of Admiral, the FTSE 100 car insurance group, has sold off a chunk of shares awarded to him through the firm's...


Dechra Pharmaceuticals has agreed to conditionally acquire the entire issued share capital of Eurovet Animal Health, a vetinary pharmaceuticals busine...


Antofagasta: AlphaValue upgrades from reduce to add, target cut from 1,233.6p to 1,211.5p. Aveva: Merchant Securities raises target from 1,785p to 1,...


Veterinary pharmaceutical firm Dechra Pharmaceuticals saw a slight fall in interim pre-tax profits and a softening of gross margins in its Services di...


Admiral: Nomura reiterates buy recommendation and 1,100p target; Credit Suisse upgrades to outperform from neutral, lifts target from 1,100p to 1,300p...